Syngene expands global footprint with US biologics manufacturing facility acquisition
Syngene International Limited, a leading contract research, development, and manufacturing organization (CRDMO), has acquired its first biologics manufacturing facility in the United States. The newly ... Read More
Syngene International launches advanced protein production platform
Syngene International Ltd. (NSE: SYNGENE), a prominent global contract research, development, and manufacturing organization (CRDMO), has announced the launch of a new protein production platform. ... Read More
Syngene International finalizes Rs 617cr acquisition of biologics facility from Stelis Biopharma
Syngene International has announced the conclusion of its acquisition of a multi-modal biologics manufacturing facility, known as ‘Unit 3’, from Stelis Biopharma Ltd. The deal ... Read More
Syngene to acquire Stelis Biopharma’s biologics manufacturing facility in Bangalore
Pharma manufacturing services company Syngene International has unveiled plans to acquire Unit 3 biologics manufacturing facility located in Bangalore, India from Stelis Biopharma Limited (SBL). ... Read More
Syngene incorporates new subsidiary Syngene Manufacturing Solutions
Syngene International said that it has incorporated a fully-owned subsidiary called Syngene Manufacturing Solutions Limited (SMSL). Syngene Manufacturing Solutions will be involved in the manufacturing ... Read More
Syngene signs Librela-focused biologics manufacturing agreement with Zoetis
Syngene International Limited has signed a 10-year biologics manufacturing agreement with American animal health company Zoetis for manufacturing the drug substance for Librela (bedinvetmab), a ... Read More